Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 1.22M | 1.22M | 1.29M |
| Total Other Revenue | 134.90K | 138.70K | 360.40K | 359.60K | 297.90K |
| Total Revenue | 134.90K | 138.70K | 1.58M | 1.58M | 297.90K |
| Cost of Revenue | -- | -- | 660.30K | 658.90K | -- |
| Gross Profit | 134.90K | 138.70K | 921.20K | 919.30K | 297.90K |
| SG&A Expenses | 397.30K | 408.50K | 1.94M | 1.94M | 586.50K |
| Depreciation & Amortization | 20.90K | 21.50K | 83.80K | 83.60K | 50.40K |
| Other Operating Expenses | 171.40K | 176.20K | 562.30K | 561.10K | 377.60K |
| Total Operating Expenses | 589.60K | 606.20K | 3.37M | 3.36M | 1.01M |
| Operating Income | -454.70K | -467.60K | -1.79M | -1.79M | -716.60K |
| Income Before Tax | -994.70K | -1.02M | -1.84M | -1.84M | -691.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -994.70K | -1.02M | -1.84M | -1.84M | -691.00K |
| Earnings from Discontinued Operations | -336.80K | -346.30K | -- | -- | -1.40M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.33M | -1.37M | -1.84M | -1.84M | -2.09M |
| EBIT | -454.70K | -467.60K | -1.79M | -1.79M | -716.60K |
| EBITDA | -433.80K | -446.00K | -1.71M | -1.70M | -666.20K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 144.27M | 144.27M | 149.02M | 149.02M | 115.42M |
| Average Diluted Shares Outstanding | 144.27M | 144.27M | 149.02M | 149.02M | 115.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |